Marty Hughes

Marty Hughes is an accomplished professional in the pharmaceutical industry, currently serving as the Executive Director of CMC at Immuneering Corporation since January 2024, where responsibilities include leading drug substance and product manufacturing processes and overseeing CDMO activities for nonclinical and clinical development. Previously, Marty held multiple roles at Cidara Therapeutics from January 2016 to January 2024, including Senior Director of Technical Operations and Senior Director of Pharmaceutical Sciences, with significant contributions to the CMC development of REZZAYO and commercial supply chain management. Prior experience includes leadership positions in research and development at Hikma Pharmaceuticals and Boehringer Ingelheim, as well as roles at PharmaForce, Sonus Pharmaceuticals, and a forensic toxicologist position with the State of Washington. Marty holds a Ph.D. in Chemistry from the University of Notre Dame, a postdoctoral degree in Clinical Chemistry from the University of Washington - School of Medicine, and a B.S. in Chemistry from Eastern Washington University.